Navigation Links
Blood Pressure Drug May Not Ease Irregular Heartbeat
Date:4/15/2009

Despite earlier promise, valsartan fails to deliver against atrial fibrillation, researchers say

WEDNESDAY, April 15 (HealthDay News) -- The blood pressure drug valsartan may not prevent episodes of a dangerous abnormal heart rhythm called atrial fibrillation, an Italian study finds.

Earlier research had suggested that valsartan (Diovan) might reduce the occurrence of atrial fibrillation, a faulty heartbeat that can lead to the formation of clots that can cause heart attack or stroke.

"But in the patients we randomized in this study, it was not useful in preventing recurrence," said study author Dr. Aldo P. Maggioni, director of the ANMCO Research Center in Florence. His team published the findings in the April 16 issue of the New England Journal of Medicine.

The new study included 1,442 people who had two or more recent episodes of atrial fibrillation, in which the upper chambers of the heart flutter uselessly rather than pumping blood. Half were given valsartan, while the other half got a placebo.

Over a one-year follow-up, the incidence of atrial fibrillation episodes was about equal in both groups, occurring in 51.4 percent of those taking valsartan and 52.1 percent of those taking placebo.

That finding does not completely rule out using valsartan -- or other members of the angiotensin II-receptor blocker family to which that drug belongs -- for certain patients with atrial fibrillation, Maggioni said. "In primary prevention or after a few episodes, an angiotensin-receptor blocker could be useful," he added. "But for recurrent atrial fibrillation, it is probably too late."

And the study does not exclude the use of valsartan to prevent atrial fibrillation in people with heart failure, a separate cardiac ailment in which the heart loses ability to pump blood, said Dr. Anne M. Gillis, director of the arrhythmia program at the University of Calgary in Canada, who wrote an accompanying editorial.

"Only 8 percent of the people in the study had heart failure," Gillis noted. "In other studies, there has been a significant reduction of atrial fibrillation in patients with heart failure."

The Italian trial also included very few people with paroxysmal atrial fibrillation, in which abnormal heartbeat occurs only occasionally, she said, leaving open the possibility that valsartan might be of help to those patients.

The drug does have its uses in helping to control high blood pressure and "in patients who have heart failure, where it is an established therapy where ACE inhibitors are not indicated," Gillis said.

But as it now stands "there is no evidence that valsartan is effective as a secondary prevention strategy" for atrial fibrillation, she said.

More information

There's more on atrial fibrillation at the American Heart Association.



SOURCES: Aldo P. Maggioni, M.D., director, ANMCO Research Center, Florence, Italy; Anne M. Gillis, professor, medicine, and director, arrhythmia program, University of Calgary, Alberta, Canada; April 16, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Specific antagonism lowers blood pressure
2. Restricting Blood Flow May Help Heart Bypass Patients
3. FDA Updates Prescription Guidelines for Blood Thinner
4. Doctors Often Miss High Blood Pressure in Kids
5. Back to School Means Return of School Blood Drives
6. Blood-flow detector software show promise in preventing brain damage
7. FDA Approves New Roche West Nile Virus Blood Screening Test
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Laser blasts viruses in blood
10. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
11. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Pressure Drug May Not Ease Irregular Heartbeat
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
Breaking Medicine Technology: